Everyone is talking about AI and machine learning’s potential for drug discovery, clinical trial management, and precision medicine. What’s less clear is how—and to what degree—these advancements will have ripple effects across the industry and for patients. Will pharma bend the healthcare cost curve? Which beyond the pill solutions will they embrace? These are the questions that Iya Khalil, co-founder and chief commercial officer of GNS Healthcare, and fellow panelists will explore at the Rock Health Enterprise Insights Forum on June 19th.
Other panelists include:
- John M. Baldoni, Senior Vice President, In silico Drug Discovery, GSK Pharma R&D;
- Bruce Palsulich, Vice President of Product Strategy, Oracle Health Sciences Global Business Unit;
- John Piccone, Principal, ZS Associates
- Moderator: Rebecca Robbins, Business Reporter, STAT News
Visit the Enterprise Insights website for more information.